«

»

U.S. Could Authorize Novavax Covid Vaccine—An MRNA Alternative—In February, CEO Says

The nanoparticle-based vaccine is already available for use in 170 countries, CEO Stanley Erck said.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive